1. Home
  2. KALV vs YB Comparison

KALV vs YB Comparison

Compare KALV & YB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALV
  • YB
  • Stock Information
  • Founded
  • KALV N/A
  • YB 2019
  • Country
  • KALV United States
  • YB China
  • Employees
  • KALV N/A
  • YB N/A
  • Industry
  • KALV Biotechnology: Pharmaceutical Preparations
  • YB
  • Sector
  • KALV Health Care
  • YB
  • Exchange
  • KALV Nasdaq
  • YB NYSE
  • Market Cap
  • KALV 642.3M
  • YB 696.5M
  • IPO Year
  • KALV N/A
  • YB 2025
  • Fundamental
  • Price
  • KALV $14.31
  • YB $28.54
  • Analyst Decision
  • KALV Strong Buy
  • YB
  • Analyst Count
  • KALV 9
  • YB 0
  • Target Price
  • KALV $26.29
  • YB N/A
  • AVG Volume (30 Days)
  • KALV 2.0M
  • YB 188.9K
  • Earning Date
  • KALV 07-10-2025
  • YB 09-05-2025
  • Dividend Yield
  • KALV N/A
  • YB N/A
  • EPS Growth
  • KALV N/A
  • YB N/A
  • EPS
  • KALV N/A
  • YB 3.12
  • Revenue
  • KALV N/A
  • YB $493,356,990.00
  • Revenue This Year
  • KALV N/A
  • YB N/A
  • Revenue Next Year
  • KALV $347.19
  • YB N/A
  • P/E Ratio
  • KALV N/A
  • YB $9.50
  • Revenue Growth
  • KALV N/A
  • YB 59.97
  • 52 Week Low
  • KALV $7.30
  • YB $14.04
  • 52 Week High
  • KALV $16.32
  • YB $31.00
  • Technical
  • Relative Strength Index (RSI)
  • KALV 58.58
  • YB N/A
  • Support Level
  • KALV $11.10
  • YB N/A
  • Resistance Level
  • KALV $16.32
  • YB N/A
  • Average True Range (ATR)
  • KALV 1.10
  • YB 0.00
  • MACD
  • KALV 0.36
  • YB 0.00
  • Stochastic Oscillator
  • KALV 68.95
  • YB 0.00

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.

About YB YUANBAO INC. SPON ADS EACH REP 6 CL A ORD

Yuanbao Inc is a technology-driven online insurance distributor in China.

Share on Social Networks: